Skip to content
London Dice Insight

Patients Coming Off Anti-Obesity Medications Regain Weight Far More Rapidly Compared to Dieters

Illustration of medical injection and weighing machine
Weight management often requires ongoing approaches.

Fresh analysis suggests that individuals who stop using popular weight-loss injections like Mounjaro or Wegovy may regain reduced body mass much more quickly than those who end conventional diet and exercise programs.

Findings released in a prominent medical journal demonstrates that while overweight people frequently drop substantial amounts of their total mass while undergoing treatment, the mass returns at an estimated rate of nearly a kilo each month once they quit.

"Users using these medications need to be aware of the potential of rapid weight regain when the therapy concludes," stated lead investigator Dr. Susan Jebb.

Such speed of regain means a reversion to pre-treatment mass in about 18 months.

Analyzing Treatments

The study, which reviewed 37 of studies involving thousands of patients, compared the outcomes of the injectable medications with conventional dieting.

Scientists emphasize that people who lose weight through diet and exercise generally have a more gradual creep back—around 100 grams monthly—post-intervention.

Understanding the Rapid Regain

Doctors propose the mechanism of the injections accounts for the accelerated weight return.

The injections copy a natural hormone called GLP-1, which helps regulate appetite.

"Long-term administration of GLP-1 levels several times higher than normal could lead to the body to generate a reduced amount of its own natural hormone, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this hormone supplement leads to appetite is uncontrolled, making overeating far more likely."

An Ongoing Issue?

The NHS recommend the jabs for individuals with obesity-related medical conditions, alongside recommended diet and exercise modifications.

A number of clinicians contend that, due to the likelihood of relapse, the therapy might need to be life-long.

This perspective is supported by drug manufacturers, who state that the findings "emphasize the long-term character of excess weight," similar to managing conditions like high blood pressure.

User Accounts

People who have come off the medication explain a sudden resurgence of cravings.

"It felt as if a trigger that goes on and you're instantly ravenous," recalled an individual.

The struggle is exacerbated if patients have not developed permanent dietary or behavioural modifications during therapy.

Significant Use

Survey data indicate that a significant number of people in the UK have used weight-loss jabs in the past year, with interest remaining high.

  • Adoption is greater among women than males.
  • The 40s and 50s age group shows the highest level of interest.
  • A large proportion obtain the drugs through private prescriptions rather than the NHS.

In conclusion, researchers stress that while the jabs are effective tools for shedding pounds, they are not a permanent solution and lasting health benefits relies on integrated lifestyle changes.

DR
Written by

Daniel Ruiz

James Whitfield is a seasoned dice strategist and reviewer based in London, with over a decade of experience analyzing dice games.

London Dice Insight

Type to search articles.